Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts
- PMID: 9697986
- PMCID: PMC1905007
- DOI: 10.1046/j.1365-2249.1998.00618.x
Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts
Abstract
Pirfenidone has been shown to modify some cytokine regulatory actions and inhibit fibroblast biochemical reactions resulting in inhibition of proliferation and collagen matrix synthesis by fibroblast. We have investigated the effect of pirfenidone on the expression of cell adhesion molecules. The synovial fibroblasts were treated with IL-1alpha in the presence or absence of pirfenidone (range 0-1000 microM), and assayed for the expression of adhesion molecules such as ICAM-1 and endothelial-leucocyte adhesion molecule-1 (E-selectin) by cell ELISA. Pirfenidone significantly down-regulated the expression of ICAM-1 on cultured synovial fibroblasts in a dose-dependent manner. In contrast, expression of E-selectin was not affected. Furthermore, we examined whether pirfenidone affects the cellular binding between cultured lymphocytes and IL-1alpha-stimulated synovial fibroblasts by in vitro binding assay and found their mutual binding was significantly suppressed in a dose-dependent manner by pirfenidone. It is speculated that down-regulation of ICAM-1 might be one of the novel mechanisms of action of pirfenidone. These data indicate a novel mechanism of action for pirfenidone to reduce the activation of synovial fibroblasts.
Figures



Similar articles
-
Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.Rheumatology (Oxford). 2006 Jul;45(7):824-32. doi: 10.1093/rheumatology/kel026. Epub 2006 Jan 31. Rheumatology (Oxford). 2006. PMID: 16449361
-
Inhibitory effect of clarithromycin on costimulatory molecule expression and cytokine production by synovial fibroblast-like cells.Clin Exp Immunol. 1996 Jun;104(3):501-8. doi: 10.1046/j.1365-2249.1996.46752.x. Clin Exp Immunol. 1996. PMID: 9099936 Free PMC article.
-
Downregulation of intercellular adhesion molecule-1 expression on human synovial fibroblasts by endothelin-1.J Rheumatol. 1999 Mar;26(3):522-31. J Rheumatol. 1999. PMID: 10090156
-
Role of cytokines in inflammatory synovitis. The coordinate regulation of intercellular adhesion molecule 1 and HLA class I and class II antigens in rheumatoid synovial fibroblasts.Arthritis Rheum. 1990 Dec;33(12):1776-86. doi: 10.1002/art.1780331204. Arthritis Rheum. 1990. PMID: 1701992
-
Endothelin-1 modulates the expression of adhesion molecules on fibroblast-like synovial cells (FLS).Scand J Rheumatol. 1996;25(4):246-56. doi: 10.3109/03009749609069994. Scand J Rheumatol. 1996. PMID: 8792802
Cited by
-
Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.J Biomed Biotechnol. 2004;2004(2):79-85. doi: 10.1155/S1110724304308107. J Biomed Biotechnol. 2004. PMID: 15240917 Free PMC article.
-
Pirfenidone: in idiopathic pulmonary fibrosis.Drugs. 2011 Sep 10;71(13):1721-32. doi: 10.2165/11207710-000000000-00000. Drugs. 2011. PMID: 21902295 Review.
-
Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.PLoS One. 2015 Aug 26;10(8):e0136160. doi: 10.1371/journal.pone.0136160. eCollection 2015. PLoS One. 2015. PMID: 26308723 Free PMC article.
-
South-West of England's Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF).Front Pharmacol. 2018 Dec 17;9:1480. doi: 10.3389/fphar.2018.01480. eCollection 2018. Front Pharmacol. 2018. PMID: 30618768 Free PMC article.
-
Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals.Mol Cell Biochem. 2000 Jan;204(1-2):119-26. doi: 10.1023/a:1007023532508. Mol Cell Biochem. 2000. PMID: 10718632
References
-
- Hale LP, Martin ME, McCollum DE, et al. Immunohistologic analysis of the distribution of cell adhesion molecules within the inflammatory synovial microenvironment. Arthritis Rheum. 1989;32:22–29. - PubMed
-
- Schwachula A, Riemann D, Kehlen A, et al. Characterization of the immunophenotype and functional properties of fibroblast-like synoviocytes in comparison to skin fibroblasts and umbilical vein endothelial cells. Immunobiol. 1994;190:67–92. - PubMed
-
- Rothein R, Dustin ML, Marlin SD, et al. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol. 1986;137:1270–3. - PubMed
-
- Dustin ML, Rothlein AK, Bhan CA, et al. Induction by IL-1 and interferon-γ, tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1) J Immunol. 1986;137:245–53. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous